Search Results 41-50 of 450 for ���������������������������������������������:PC90���

  1. Mayo Clinic Comprehensive Cancer Center — Research

    The purpose of this study is to determine how patients with metastatic castration-resistant prostate cancer, and evidence of a homologous recombination gene ...

  2. 64Cu-SAR-bisPSMA and 67Cu-SAR-bisPSMA for Identification and Treatment of PSMA-expressing Metastatic Castrate Resistant Prostate Cancer (SECuRE) - Mayo Clinic

    The purpose of this study is to evaluate 64Cu-SAR-bisPSMA and 67Cu-ARbisPSMA administered to participants with metastatic castrate resistant prostate cancer ( ...

  3. Mayo Clinic Comprehensive Cancer Center — Research

    Docetaxel is an approved chemotherapeutic drug.This study is a Phase 1 open-label study of MM-310 in patients with solid tumors. In the first part of the study, ...

  4. A Study of the Safety, Tolerability, and Drug/Body Interactions of C2N-8E12 in People with Progressive Supranuclear Palsy - Mayo Clinic

    The purpose of this study is to evaluate the safety, tolerability and drug/body interactions of C2N-8E12 in patients with progressive supranuclear palsy.

  5. Study of XL092 in Combination With Immuno-Oncology Agents in Subjects With Solid Tumors - Mayo Clinic

    About this study. The purpose of this study is to evaluate the safety tolerability, PK, preliminary antitumor activity, and effect of biomarkers of XL092 ...

  6. https://www.mayoclinic.org/chinese_organization_concepts.xml

  7. This is a multi-center, open-label, Phase Ib dose escalation / Phase II study in recurrent or metastatic head and neck squamous cell carcinoma (RM HNSCC) ...

  8. A Study of BBI608 Administered With Paclitaxel in Adult Patients With Advanced Malignancies - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  9. Mayo Clinic Minute: Steam treatment for enlarged prostate VIDEO AUDIO It’s a common problem for older men

    “BPH is a fancy way of saying the prostate is getting larger, and we don't want it to.” Dr. Toby Kohler, a Mayo Clinic urologist, says the.

  10. Efficacy, Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of BIA 28-6156 in GBA-PD - Mayo Clinic

    About this study. The purpose of this study is to assess the effectiveness of BIA 28-6156 in delaying meaningful clinical motor progression in subjects with ...